Literature DB >> 24162787

Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.

Hee-Jin Kim1, Ja-Young Seo, Ki-O Lee, Sung-Hwan Bang, Seung-Tae Lee, Chang-Seok Ki, Jong-Won Kim, Chul Won Jung, Duk-Kyung Kim, Sun-Hee Kim.   

Abstract

Hereditary natural anticoagulant deficiencies are the major cause of genetic thrombophilia in Asia. Given the growing acknowledgment of the risk of venous thromboembolism in Asian populations, we investigated the frequency and mutation spectrums of natural anticoagulant deficiency in Korea. The group of patients consisted of consecutive patients with venous thromboembolism screened for thrombophilia. Genetic tests were performed on suspicion of natural anticoagulant deficiency. For the population group, >3,000 individuals were screened from routine check-ups, and those with a low level (<1(st) percentile) of natural anticoagulant underwent genetic tests. Mutations were detected by direct sequencing of PROC, PROS1, and SERPINC1, followed by additional multiplex ligation-dependent probe amplification for PROS1 and SERPINC1 for dosage mutations. Among 500 patients screened, 127 were suspected of having a natural anticoagulant deficiency, and this was genetically confirmed in 71: protein C deficiency in 36 (50.7%), antithrombin deficiency in 21 (29.6%), and protein S deficiency in 14 (19.7%). Among 3,129 individuals from the population who were screened, the frequency of natural anticoagulant deficiency was ~1.0%: antithrombin deficiency 0.49%, protein C deficiency 0.35%, and protein S deficiency 0.16%. Two PROC mutations causing type I protein C deficiency were prevalent (Arg211Trp and Met406Ile in patients and Arg211Trp in the population). Two SERPINC1 mutations causing type II antithrombin deficiency, Arg79Cys and Ser158Pro, were prevalent in the population group. This is the first study on the genetic epidemiology of natural anticoagulant deficiencies in Korea. The results demonstrated that the frequencies and spectrum of mutations underlying genetic thrombophilia in Korea are different not only from those in Caucasians but also those in other Asian populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24162787      PMCID: PMC3943322          DOI: 10.3324/haematol.2013.092023

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  48 in total

Review 1.  Venous thromboembolism in Asia--an unrecognised and under-treated problem?

Authors:  Pantep Angchaisuksiri
Journal:  Thromb Haemost       Date:  2011-08-11       Impact factor: 5.249

2.  Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort.

Authors:  Michael Caspers; Anna Pavlova; Julia Driesen; Ursula Harbrecht; Robert Klamroth; Janos Kadar; Ronald Fischer; Bettina Kemkes-Matthes; Johannes Oldenburg
Journal:  Thromb Haemost       Date:  2012-05-25       Impact factor: 5.249

3.  Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.

Authors:  Tienan Zhu; Qiulan Ding; Xia Bai; Xiaoyan Wang; Florentia Kaguelidou; Corinne Alberti; Xuqian Wei; Baolai Hua; Renchi Yang; Xuefeng Wang; Zhaoyue Wang; Changgeng Ruan; Nicole Schlegel; Yongqiang Zhao
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

4.  Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China.

Authors:  Guang-sen Zhang; Yang-ming Tang; Mei-qing Tang; Zi-Ju Qing; Chang Shu; Xiang-qi Tang; Ming-yang Deng; Li-ming Tan
Journal:  Blood Coagul Fibrinolysis       Date:  2010-09       Impact factor: 1.276

5.  Heterogeneous lengths of copy number mutations in human coagulopathy revealed by genome-wide high-density SNP array.

Authors:  Hee-Jin Kim; Duk-Kyung Kim; Ki-Young Yoo; Chur-Woo You; Jong-Ha Yoo; Ki-O Lee; In-Ae Park; Hae-Sun Choung; Hee-Jung Kim; Min-Jung Song; Sun-Hee Kim
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

6.  Establishment of reference intervals for von Willebrand factor antigen and eight coagulation factors in a Korean population following the Clinical and Laboratory Standards Institute guidelines.

Authors:  Ja-Hyun Jang; Ja-Young Seo; Sung-Hwan Bang; In-Ae Park; Hee-Jin Kim; Sun-Hee Kim
Journal:  Blood Coagul Fibrinolysis       Date:  2010-04       Impact factor: 1.276

7.  Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis.

Authors:  Toshiyuki Miyata; Yukiko Sato; Junko Ishikawa; Hiromi Okada; Satoshi Takeshita; Toshiyuki Sakata; Koichi Kokame; Rina Kimura; Shigenori Honda; Tomio Kawasaki; Etsuji Suehisa; Hajime Tsuji; Seiji Madoiwa; Yoichi Sakata; Tetsuhito Kojima; Mitsuru Murata; Yasuo Ikeda
Journal:  Thromb Res       Date:  2008-10-26       Impact factor: 3.944

Review 8.  Effects of race and ethnicity on the incidence of venous thromboembolism.

Authors:  Richard H White; Craig R Keenan
Journal:  Thromb Res       Date:  2009       Impact factor: 3.944

9.  Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.

Authors:  Liang Tang; Tao Guo; Rui Yang; Heng Mei; Huafang Wang; Xuan Lu; Jianming Yu; Qingyun Wang; Yu Hu
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

10.  Hereditary thrombophilia in Korean patients with idiopathic pulmonary embolism.

Authors:  Mirae Lee; Hye Jin No; Shin Yi Jang; Nari Kim; Seung Hyuk Choi; Hojoong Kim; Sun-Hee Kim; Hee-Jin Kim; Duk-Kyung Kim
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

View more
  18 in total

1.  Protein S deficiency in patients from the French Basque Country with various thrombotic conditions: a rarer inherited trait in autochthonous individuals?

Authors:  Frédéric Bauduer
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

2.  Genetic thrombophilia and natural anticoagulants: importance of polymorphisms within and outside the genes.

Authors:  Shrimati Shetty; Kanjaksha Ghosh
Journal:  Haematologica       Date:  2014-03       Impact factor: 9.941

3.  Causative genetic mutations for antithrombin deficiency and their clinical background among Japanese patients.

Authors:  Akiko Sekiya; Fumina Taniguchi; Daisuke Yamaguchi; Sayaka Kamijima; Shonosuke Kaneko; Shiori Katsu; Miho Hanamura; Mao Takata; Haruka Nakano; Hidesaku Asakura; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2016-11-17       Impact factor: 2.490

4.  Distinctive regional-specific PROS1 mutation spectrum in Southern China.

Authors:  Nelson C N Chan; Chi-Keung Cheng; Kelvin C F Chan; Connie M L Wong; Kin-Mang Lau; Joyce H Y Kwong; Natalie P H Chan; Wai-Shan Wong; Eudora Y D Chow; Michael L G Wong; Raymond W Chu; Rosalina K L Ip; Margaret H L Ng
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

5.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

6.  Prenatal genetic testing for familial severe congenital protein C deficiency.

Authors:  Shinya Tairaku; Mariko Taniguchi-Ikeda; Yoko Okazaki; Yoriko Noguchi; Yuji Nakamachi; Takeshi Mori; Ikuko Kubokawa; Akira Hayakawa; Akio Shibata; Tomomi Emoto; Hiroki Kurahashi; Tatsushi Toda; Seiji Kawano; Hideto Yamada; Ichiro Morioka; Kazumoto Iijima
Journal:  Hum Genome Var       Date:  2015-06-25

7.  Thrombophilia in Korean patients with arterial or venous thromboembolisms.

Authors:  Sungbae Kim; Incheol Song; Hyung-Kee Kim; Seung Huh
Journal:  Ann Surg Treat Res       Date:  2016-05-30       Impact factor: 1.859

Review 8.  Thrombophilia in East Asian countries: are there any genetic differences in these countries?

Authors:  Toshiyuki Miyata; Keiko Maruyama; Fumiaki Banno; Reiko Neki
Journal:  Thromb J       Date:  2016-10-04

9.  Whole Exome Sequencing Reveals Severe Thrombophilia in Acute Unprovoked Idiopathic Fatal Pulmonary Embolism.

Authors:  Matt Halvorsen; Ying Lin; Barbara A Sampson; Dawei Wang; Bo Zhou; Lucy S Eng; Sung Yon Um; Orrin Devinsky; David B Goldstein; Yingying Tang
Journal:  EBioMedicine       Date:  2017-01-31       Impact factor: 8.143

Review 10.  Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines.

Authors:  Seung-Kee Min; Young Hwan Kim; Jin Hyun Joh; Jin Mo Kang; Ui Jun Park; Hyung-Kee Kim; Jeong-Hwan Chang; Sang Jun Park; Jang Yong Kim; Jae Ik Bae; Sun Young Choi; Chang Won Kim; Sung Il Park; Nam Yeol Yim; Yong Sun Jeon; Hyun-Ki Yoon; Ki Hyuk Park
Journal:  Vasc Specialist Int       Date:  2016-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.